Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 2
1990 1
1994 1
1997 1
1998 3
1999 2
2000 1
2001 1
2002 4
2003 4
2004 8
2005 3
2006 6
2007 7
2008 7
2009 8
2010 13
2011 8
2012 12
2013 25
2014 19
2015 11
2016 8
2017 7
2018 5
2019 2
2020 2
2021 2
2022 5
2023 1

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 19822407

149 results

Results by year

Filters applied: . Clear all
Page 1
Correlates of cognitive impairment in first episode schizophrenia: the EUFEST study.
Galderisi S, Davidson M, Kahn RS, Mucci A, Boter H, Gheorghe MD, Rybakowski JK, Libiger J, Dollfus S, López-Ibor JJ, Peuskens J, Hranov LG, Fleischhacker WW; EUFEST group. Galderisi S, et al. Schizophr Res. 2009 Dec;115(2-3):104-14. doi: 10.1016/j.schres.2009.09.022. Epub 2009 Oct 12. Schizophr Res. 2009. PMID: 19822407
Comorbid substance abuse in first-episode schizophrenia: effects on cognition and psychopathology in the EUFEST study.
Wobrock T, Falkai P, Schneider-Axmann T, Hasan A, Galderisi S, Davidson M, Kahn RS, Derks EM, Boter H, Rybakowski JK, Libiger J, Dollfus S, López-Ibor JJ, Peuskens J, Hranov LG, Gaebel W, Fleischhacker WW; EUFEST study group. Wobrock T, et al. Schizophr Res. 2013 Jun;147(1):132-139. doi: 10.1016/j.schres.2013.03.001. Epub 2013 Mar 26. Schizophr Res. 2013. PMID: 23537477 Clinical Trial.
Predictors of neurocognitive impairment at 3 years after a first episode non-affective psychosis.
Ayesa-Arriola R, Pérez-Iglesias R, Rodríguez-Sánchez JM, Pardo-García G, Tabares-Seisdedos R, Ayuso-Mateos JL, Vázquez-Barquero JL, Crespo-Facorro B. Ayesa-Arriola R, et al. Prog Neuropsychopharmacol Biol Psychiatry. 2013 Jun 3;43:23-8. doi: 10.1016/j.pnpbp.2012.11.012. Epub 2012 Dec 7. Prog Neuropsychopharmacol Biol Psychiatry. 2013. PMID: 23228461
Cognitive effects of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: a randomized, open-label clinical trial (EUFEST).
Davidson M, Galderisi S, Weiser M, Werbeloff N, Fleischhacker WW, Keefe RS, Boter H, Keet IP, Prelipceanu D, Rybakowski JK, Libiger J, Hummer M, Dollfus S, López-Ibor JJ, Hranov LG, Gaebel W, Peuskens J, Lindefors N, Riecher-Rössler A, Kahn RS. Davidson M, et al. Am J Psychiatry. 2009 Jun;166(6):675-82. doi: 10.1176/appi.ajp.2008.08060806. Epub 2009 Apr 15. Am J Psychiatry. 2009. PMID: 19369319 Clinical Trial.
149 results